FEATURED STORY

Kenyan Company Makes History in Global Covid-19 Fight

Share
A medic holds up a syringe. Revital Healthcare is one of only six companies in the world licensed by the World Health Organization (WHO) to produce auto-disable syringes.
A medic holds up a syringe. Revital Healthcare is one of only six companies in the world licensed by the World Health Organization (WHO) to produce auto-disable syringes.
Share

A Kenyan firm, Revital Healthcare (EPZ) Limited, made history after becoming the first African company licensed to produce Covid-19 vaccine syringes.

It is one of only six companies in the world licensed by the World Health Organization (WHO) to produce the specialized syringes.

Among other medical products, the company produces auto-disable syringes.

As the name suggests, the syringes can only be used once as they disable themselves immediately after, making them ideal for large-scale distribution of the vaccine.

Since receiving the WHO approval, the company has secured international supply deals including from the Bill & Melinda Gates Foundation to mass-produce the syringes.

Revital Healthcare Sales Director Roneek Vora pictured at the Moi International Airport in Mombasa on November 25, 2020.
Revital Healthcare Sales Director Roneek Vora pictured at the Moi International Airport in Mombasa on November 25, 2020.

“This approval made the Bill & Melinda Gates Foundation approach us last month to pre-plan for the vaccine syringes.

READ>>>>>Kenya Sets July Target for Covid-19 Vaccine to Save Tourism

“The foundation has partnered with us so as to mass-produce the vaccines syringes for them,” Revital Healthcare Sales Director Roneek Vora disclosed in an interview.

On Wednesday, November 25, a first shipment of 800,000 pieces was delivered to Lagos, Nigeria.

The syringes will be used in distribution of Sputnik V, Russia’s Covid-19 vaccine which Nigeria received in September.

Based in Kilifi County, Revital Healthcare employs 400 people with many of them being women.

Among products the company has been producing are immunization syringes, auto-disable syringes, Covid-19 testing kits, PPE kits and surgical face masks.

The firm has been supplying products to several countries in Africa including Kenya, Tanzania, Rwanda, Burundi, Uganda, Madagascar, Mozambique and Malawi.

Vora credited President Uhuru Kenyatta’s Big 4 agenda, which includes manufacturing, and the ‘Buy Kenya Build Kenya’ initiative for boosting confidence in their products.

He disclosed that, for the first time in its history, the company exported surgical face masks to the United Kingdom during the pandemic.

“In the 12 years that we have been in production, we have not received enquiries from outside Africa.

“But now, after the WHO license, we are getting enquiries from UK, the US, Brazil, Canada, Myanmar, Vietnam, Philippines, among other countries,” he stated.

READ>>>>>Covid-19 Vaccine Trials Begin in Kenya

 

Written by
MARTIN SIELE -

Martin K.N Siele is the Content Lead at Business Today. He is also a Quartz contributor and a 2021 Baraza Media Lab-Fringe Graph Data Storytelling Fellow. Passionate about digital media, sports and entertainment, Siele also founded Loud.co.ke

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Follow Us

Related Articles
Data protection
FEATURED STORY

Why Protecting Your Data is Key in Kenya’s Digital Era

Data protection and privacy in Kenya is enshrined in the Constitution, under...

Computer
FEATURED STORY

List Of Computer Misuse Offenses That Could Land You In Trouble With Govt

The advent of the internet is one of the greatest invention of...

The Origins of Commercial Banking in Kenya
ECONOMYFEATURED STORY

The Origins of Commercial Banking in Kenya

Kenya is rich in type, number and sophistication of financial institutions. The...

What to Know about President Ruto’s Planned Nationwide Livestock Vaccination Programme
FEATURED STORYNEWS

What to Know about President Ruto’s Planned Nationwide Livestock Vaccination Programme

The nationwide livestock vaccination programme “against diseases,” planned for January next year,...